Work

Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy

Year: 2023

Type: review

Source: The Lancet Respiratory Medicine

DOI: 10.1016/s2213-2600(23)00324-7

Authors: Katherine B Hisert, Susan E Birket, John Paul Clancy, Damian G Downey, John F Engelhardt, Isabelle Fajac, Robert D Gray, Marrah E Lachowicz-Scroggins, Nicole Mayer-Hamblett, Patrick Thibodeau, Katherine L Tuggle, Claire E Wainwright, Kris De Boeck

Institutions: National Jewish Health, University of Alabama at Birmingham, Cystic Fibrosis Foundation, Queen's University Belfast, University of Iowa, Université Paris Cité, Assistance Publique – Hôpitaux de Paris, Centre for Inflammation Research, University of Edinburgh, National Institutes of Health, National Heart, Lung, and Blood Institute, University of Washington, Seattle Children's Research Institute, The University of Queensland, KU Leuven

Language: English

Topic: Cystic Fibrosis Research Advances

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: U.S. Department of Health and Human Services, Cystic Fibrosis Foundation, National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Center for Advancing Translational Sciences

Awards: Early Pathogenesis of Cystic Fibrosis Related Diabetes, G248024899, G336615015, G5703857491, Modulating macrophage-mediated Inflammation in cystic fibrosis, Precision Medicine Center for Cystic Fibrosis

OpenAlex ID: W4386575375

FWCI: 2.758

Cites: 139

Cited by: 59

Related to: 10